Search research articles
Contact Us
Filters
Showing results (181-190 of 282) with videos related to
Page
of 29
Sort By:
Scientific Reports
|
December 29, 2019
C. elegans expressing D76N β<sub>2</sub>-microglobulin: a model for in vivo screening of drug candidates targeting amyloidosis
Giulia Faravelli, Sara Raimondi, Loredana Marchese, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
June 19, 2016
Development of the Galaxy Chronic Obstructive Pulmonary Disease (COPD) Model Using Data from ECLIPSE: Internal Validation of a Linked-Equations Cohort Model
Andrew H Briggs, Timothy Baker, Nancy A Risebrough, et al.
BMC Pulmonary Medicine
|
November 7, 2013
Nitric oxide synthase polymorphisms, gene expression and lung function in chronic obstructive pulmonary disease
Farzian Aminuddin, Tillie-Louise Hackett, Dorota Stefanowicz, et al.
Respiratory Research
|
September 14, 2010
Characterisation of COPD heterogeneity in the ECLIPSE cohort
Alvar Agusti, Peter M A Calverley, Bartolome Celli, et al.
Developmental Cell
|
March 5, 2021
Conversion of the death inhibitor ARC to a killer activates pancreatic β cell death in diabetes
Wendy M McKimpson, Yun Chen, James A Irving, et al.
Thrombosis and Haemostasis
|
March 6, 2007
Expression of the serine protease inhibitor neuroserpin in cells of the human myeloid lineage
Sarah A Kennedy, Angela C van Diepen, Cecilia M van den Hurk, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 26, 2020
The Effect of Inhaled Corticosteroid Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study. A Randomized, Double-Blind, Multicenter Clinical Trial
MeiLan K Han, Gerard J Criner, Mark T Dransfield, et al.
Plos One
|
March 23, 2018
The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A randomised double-blind placebo-controlled trial
Marie Fisk, Joseph Cheriyan, Divya Mohan, et al.
Thorax
|
June 15, 2012
Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease
Paul Albert, Alvar Agusti, Lisa Edwards, et al.
COPD
|
May 30, 2013
The COPD Biomarker Qualification Consortium (CBQC)
Richard Casaburi, Bartolome Celli, James Crapo, et al.
Page
of 29
Search research articles
Search
Showing results (181-190 of 282) with videos related to
Sort By:
Page
of 29
Scientific Reports
|
December 29, 2019
C. elegans expressing D76N β<sub>2</sub>-microglobulin: a model for in vivo screening of drug candidates targeting amyloidosis
Giulia Faravelli, Sara Raimondi, Loredana Marchese, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
June 19, 2016
Development of the Galaxy Chronic Obstructive Pulmonary Disease (COPD) Model Using Data from ECLIPSE: Internal Validation of a Linked-Equations Cohort Model
Andrew H Briggs, Timothy Baker, Nancy A Risebrough, et al.
BMC Pulmonary Medicine
|
November 7, 2013
Nitric oxide synthase polymorphisms, gene expression and lung function in chronic obstructive pulmonary disease
Farzian Aminuddin, Tillie-Louise Hackett, Dorota Stefanowicz, et al.
Respiratory Research
|
September 14, 2010
Characterisation of COPD heterogeneity in the ECLIPSE cohort
Alvar Agusti, Peter M A Calverley, Bartolome Celli, et al.
Developmental Cell
|
March 5, 2021
Conversion of the death inhibitor ARC to a killer activates pancreatic β cell death in diabetes
Wendy M McKimpson, Yun Chen, James A Irving, et al.
Thrombosis and Haemostasis
|
March 6, 2007
Expression of the serine protease inhibitor neuroserpin in cells of the human myeloid lineage
Sarah A Kennedy, Angela C van Diepen, Cecilia M van den Hurk, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 26, 2020
The Effect of Inhaled Corticosteroid Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study. A Randomized, Double-Blind, Multicenter Clinical Trial
MeiLan K Han, Gerard J Criner, Mark T Dransfield, et al.
Plos One
|
March 23, 2018
The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A randomised double-blind placebo-controlled trial
Marie Fisk, Joseph Cheriyan, Divya Mohan, et al.
Thorax
|
June 15, 2012
Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease
Paul Albert, Alvar Agusti, Lisa Edwards, et al.
COPD
|
May 30, 2013
The COPD Biomarker Qualification Consortium (CBQC)
Richard Casaburi, Bartolome Celli, James Crapo, et al.
Page
of 29